(Q43442634)

23 November 2017

title

Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas (English)

1 reference

23 November 2017

0 references

3

Gu Seob Roh

1 reference

23 November 2017

Young Hee Kim

1

1 reference

23 November 2017

Yoon Sook Kim

series ordinal

2

1 reference

23 November 2017

Wan Sung Choi

series ordinal

4

1 reference

23 November 2017

Gyeong Jae Cho

series ordinal

5

1 reference

23 November 2017

publication date

13 September 2011

1 reference

23 November 2017

1 reference

23 November 2017

volume

90

1 reference

23 November 2017

issue

1

1 reference

23 November 2017

page(s)

e31-7

1 reference

Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic Acid

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Diabetic retinopathy and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Resveratrol: from basic science to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Improvement of neovascularization capacity of bone marrow mononuclear cells from diabetic mice by ex vivo pretreatment with resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Resveratrol: a multitargeted agent for age-associated chronic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

VEGF164Is Proinflammatory in the Diabetic Retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Changes in rhodopsin kinase and transducin in the rat retina in early-stage diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Triamcinolone suppresses retinal vascular pathology via a potent interruption of proinflammatory signal-regulated activation of VEGF during a relative hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Protein kinase C delta regulates anti-apoptotic alphaB-crystallin in the retina of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Triamcinolone acetonide protects the rat retina from STZ-induced acute inflammation and early vascular leakage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Protein kinase C-delta mediates neuronal apoptosis in the retinas of diabetic rats via the Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Glial cell-derived cytokines attenuate the breakdown of vascular integrity in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Resveratrol: a natural compound with pharmacological potential in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

SIRT1 activation confers neuroprotection in experimental optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Microvascular basement membranes in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2011.02243.X

10.1111/J.1755-3768.2011.02243.X

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference